Optimal

Daniel Currie

Updated 26 April 21

Improving management of child respiratory care who unable to use a spirometer, by objective assessment of their breathing.

optimising.care

Check out our case study

digital health hardware

Comments

Sign up to our free mentorship programme!

RISK WARNING:Please read our full risk warning and disclaimer: https://invest.wearenova.co.uk/risk

Investments of this nature carry risks to your capital. The risks include illiquidity where shares may not be able to be sold easily, lack of dividends and dilution. Past performance is not indicative of future returns. Investors should only invest a proportion of their available investment funds into Nova Cofoundery SEIS & EIS Fund as these investments are high risk.

The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, is only available for UK investors in qualifying companies and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.

Nova Growth Capital Limited is an Appointed Representative of Sapphire Capital Partners LLP, which is authorised and regulated by the Financial Conduct Authority (FRN 565716).

Optimal

Daniel Currie

Share:

Share:

Comments

Sign up to our free mentorship programme!

Related Content

Q&A with Nova's Head of Pipeline

Nova Founder insights: A Q&A with the Found...

Sports & Wellness programme, April cohort -...

How To Create Killer Facebook Ads for Your ...